• Explore /
  • Poster
  • / IMPACT trial: Predictive factors for maintenance therapy with MGN1703 in patients with metastatic colorectal carcinoma.

IMPACT trial: Predictive factors for maintenance therapy with MGN1703 in patients with metastatic colorectal carcinoma.

Abstract Poster

Authors

null

Jorge Riera-Knorrenschild

Universitätsklinikum Giessen und Marburg, Marburg, Germany

Jorge Riera-Knorrenschild , Werner Scheithauer , Hendrik Kröning , Frank Mayer , Dieter Nitsche , Reinhard Ziebermayr , Johannes Andel , Dirk Arnold , Burghardt Wittig , Hans-Joachim Schmoll

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT01208194

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3615)

DOI

10.1200/jco.2014.32.15_suppl.3615

Abstract #

3615

Poster Bd #

78

Abstract Disclosures

Similar Posters

First Author: Jorge Riera-Knorrenschild

First Author: Thomas Hoehler

First Author: Axel Grothey

First Author: Reema Anil Patel